This isn’t just a pen, it’s a tool of legacy, a spark of innovation, and a story waiting to be told. Boulder City, Nevada, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Fisher Space Pen Co. proudly announces the ...

Boulder City, Nevada, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Fisher Space Pen Co. proudly announces the release of its newest special edition: the AG7 Space Pen, now armored in Graphite Black Cerakote and ...

Fisher’s space dreams began when she was a 12-year-old “army brat”. Born Anna Tingle and raised on military bases across the US, she was living in Kentucky when she heard the 1961 radio broadcast of ...

NEW YORK – Thermo Fisher Scientific, Genovation Health, and XYGene have signed a multiyear comarketing collaboration agreement aimed at expanding access to integrated genomic solutions, the firms ...

On June 10, 1943, the patent for the ballpoint pen was filed. To celebrate National Ballpoint Pen Day (#BallpointPenDay), we've pulled together writing implements from across our collection.

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ Orbitrap Exploris™ EFOX Mass Detector, the industry’s first high ...

New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic research WALTHAM, Mass.--(BUSINESS WIRE) ...

Cristiano Ronaldo shared insight into how his and fiancée Georgina Rodríguez’s relationship grew stronger after losing their baby boy, Angel, in 2022. Taylor Swift and Travis Kelce stepped out for ...

People in Stone, Great Wyrley and Penkridge have access to more local green space than the average across England, new analysis shows. The figures come from a new analysis of environmental threats by ...

Did you find this article by typing in the name of a website associated with Elon Musk? Did it sound like you could invest in SpaceX, Neuralink, or one of Musk’s AI ventures like Grok and xAI? It’s ...

Armed with new clinical trial results, Amgen is expanding studies of its KRAS inhibitor Lumakras in pancreatic cancer, as it tries to extend the label for the first-in-class drug beyond its current ...